Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BKCC

BlackRock Capital Investment (BKCC) Stock Price, News & Analysis

BlackRock Capital Investment logo

About BlackRock Capital Investment Stock (NASDAQ:BKCC)

Advanced Chart

Key Stats

Today's Range
$3.66
$3.70
50-Day Range
$3.62
$3.82
52-Week Range
$3.03
$4.03
Volume
162,805 shs
Average Volume
227,142 shs
Market Capitalization
$267.06 million
P/E Ratio
10.22
Dividend Yield
10.87%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BKCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Capital Investment and its competitors with MarketBeat's FREE daily newsletter.

BKCC Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
BlackRock Inc DRC (BLAK34)
See More Headlines

BKCC Stock Analysis - Frequently Asked Questions

BlackRock Capital Investment Co. (NASDAQ:BKCC) issued its quarterly earnings data on Monday, May, 1st. The asset manager reported $0.12 EPS for the quarter, topping analysts' consensus estimates of $0.11 by $0.01. The asset manager earned $18.76 million during the quarter, compared to the consensus estimate of $18.12 million. BlackRock Capital Investment had a net margin of 32.65% and a trailing twelve-month return on equity of 11.54%.
Read the conference call transcript
.

BlackRock Capital Investment subsidiaries include these companies: Summit Companies, National Renewable Solutions, Transaction Data Systems, Aquila Heywood, Aperio, eFront, Tennenbaum Capital Partners LLC, and more.

Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Capital Investment investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet (CLMT), Two Harbors Investments (TWO), NovoCure (NVCR), Rithm Capital (RITM) and Summit Midstream Partners (SMLP).

Company Calendar

Last Earnings
5/01/2023
Today
8/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Management consulting services
Sub-Industry
Asset Management & Custody Banks
Current Symbol
NASDAQ:BKCC
CIK
1326003
Employees
N/A
Year Founded
1988

Profitability

EPS (Trailing Twelve Months)
$0.36
Trailing P/E Ratio
10.22
Forward P/E Ratio
8.36
P/E Growth
N/A
Net Income
$26.24 million
Net Margins
32.65%
Pretax Margin
32.65%
Return on Equity
11.54%
Return on Assets
5.93%

Debt

Debt-to-Equity Ratio
0.93
Current Ratio
1.11
Quick Ratio
1.11

Sales & Book Value

Annual Sales
$80.36 million
Price / Sales
3.32
Cash Flow
$0.47 per share
Price / Cash Flow
7.84
Book Value
$4.35 per share
Price / Book
0.85

Miscellaneous

Outstanding Shares
72,570,000
Free Float
71,375,000
Market Cap
$267.06 million
Optionable
Optionable
Beta
1.41

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:BKCC) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners